Skip Ribbon Commands
Skip to main content
Menu
Dr Ho Liam Pock

Dr Ho Liam Pock

​MBBS, FRCPA

Senior Consultant

Singapore General Hospital

Specialty: Pathology

Sub-specialties: Haematopathology

Conditions Treated by this Doctor:
Acute Lymphocytic Leukemia (ALL), Aplastic Anaemia, Chronic lymphocytic leukemia, Chronic Myeloid Leukemia (CML), Deep Vein Thrombosis, Deep Vein Thrombosis, essential thrombocythemia, Haemophilia and other bleeding disorders, Multiple Myeloma, Myelodysplastic Syndromes, Myelofibrosis, Polycythemia Vera, Thalassaemia.

Clinical Appointments

  • Senior Consultant SingHealth Duke-NUS Blood Cancer Centre
  • Senior Consultant Clinical Pathology Singapore General HospitalSingapore General Hospital
  • Senior Consultant Haematology Singapore General HospitalSingapore General Hospital
  • Visiting Consultant Department of Pathology Sengkang General HospitalSengkang General Hospital

Profile

Dr Ho is a Senior Consultant with the Department of Pathology and Department of Haematology.

Education

  • ​1994 National University of Singapore: Bachelor of Medicine, Bachelor of Surgery (MBBS) 
  • 2001 Health Manpower Development Program (HMDP) in Hematopathology in 
  • Sydney, Australia 
  • 2002 Fellow of the Royal College of Pathologists of Australasia (FRCPA)

Professional Appointments and Committee Memberships

  • ​Member, Singapore Medical Association 
  • Member, Singapore Society of Pathology 
  • Member, Singapore Hematology Society 
  • 2nd Secretary, Singapore Society of Pathology, 2004 
  • DRG Representative, Department of Pathology, 2004 
  • Team Leader, Clinical Practice Improvement Project, 2004 
  • Clinical Pathway Representative, Department of Pathology, 2004 
  • Committee Member, Division of ACSS EBM committee, 2006-2007 
  • Committee Member, Division of ACSS Education/Training Updates committee, 2006-2007 
  • Clinical Coordinator, Department of Pathology, 2007 
  • Honorary Treasurer, Organising Committee for 5th APSTH Meeting in 2008

Awards

Research Interests

  • Immunotherapy for breast cancer

Publications

  • FVIII gene delivery by muscle electroporation corrects murine hemophilia A, Journal of gene medicine 2004, Vol 7, Issue 4, page 494-505. 
  • In vivo liver electroporation: Optimisation and demonstration of therapeutic efficacy, 
  • Journal of Human Gene Therapy 2006, Vol 17, page 1-14. 
  • Case Report: Induction of Immune Tolerance to Factor VIII Inhibitor during a major operation. (Ann Acad Med Singapore, 2007, 36 page 431-434) 
  • Studies of Wilms' tumor (WT1) Gene Expression in Adult Acute Leukemias in Singapore. Biomarker Insights, 2007, 3, page 293-298. 
Research Project:
  • Cytotoxic Potential of Autologous cytokine-induced killers cells (CIK) after priming by  AML-blast-derived dendritic cells - Collaborator, DCR Research Grant 2002­2003 
  • Cytotoxic Potential of Autologous cytokine-induced killers cells (CIK) after priming by AML-blast-derived dendritic cells - Collaborator, Singhealth Research Grant 2003. 
  • Feasibility study of large scale expansion of cytokine induced killer (CIK) cells ­ Collaborator, DCR Grant 2003. 
  • Expansion of tolerogenic thymic dendritic cells -Collaborator, DCR Grant 2004­2005. 
  • Non-myeloablative allogenic stem cell transplantation and targeted cellular therapy for leukemias and other cancers - Collaborator, Cancer Syndicate Infrastructure Initiative 2003-2006. 
  • Bone Marrow Transplant Consortium - Collaborator, Singapore Cancer Syndicate Grant 2006-7. 
  • Memory T cell- A Short Rest before the Long Journey. Pending Singhealth grant application 2008. 
  • Memory T cell - A Short Rest before the Long Journey. Pending DCR grant application 2008. 
  • A study into the impact of immunosuppressive cells on the outcome of patients with  hematological and solid organ cancers undergoing chemotherapy. Pending Singhealth grant application 2008. 

Research Trials